These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 22525317)
1. Derivatives of 8-hydroxyquinoline--antibacterial agents that target intra- and extracellular Gram-negative pathogens. Enquist PA; Gylfe A; Hägglund U; Lindström P; Norberg-Scherman H; Sundin C; Elofsson M Bioorg Med Chem Lett; 2012 May; 22(10):3550-3. PubMed ID: 22525317 [TBL] [Abstract][Full Text] [Related]
2. Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Dahlgren MK; Zetterström CE; Gylfe S; Linusson A; Elofsson M Bioorg Med Chem; 2010 Apr; 18(7):2686-703. PubMed ID: 20219378 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-methyl-3-methylaminopiperidin-1-yl)quinolones. Wan ZL; Chai Y; Liu ML; Guo HY; Sun LY Yao Xue Xue Bao; 2010 Jul; 45(7):860-8. PubMed ID: 20931783 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted oxadiazolo pyrrolidin-3-yl-thio)carbapenem derivatives. Oh CH; Dong HG; Lee JS; Lee SC; Hong JH; Cho JH Arch Pharm (Weinheim); 2003 Dec; 336(12):567-72. PubMed ID: 14677150 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and evaluation of novel polypharmacological antichlamydial agents. Sunduru N; Salin O; Gylfe Å; Elofsson M Eur J Med Chem; 2015 Aug; 101():595-603. PubMed ID: 26204507 [TBL] [Abstract][Full Text] [Related]
6. A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships. Yamawaki K; Nomura T; Yasukata T; Uotani K; Miwa H; Takeda K; Nishitani Y Bioorg Med Chem; 2007 Nov; 15(21):6716-32. PubMed ID: 17723304 [TBL] [Abstract][Full Text] [Related]
8. In vitro studies of the antibacterial and antifungal activity of oxine and its derivatives. Khan KA; Khan SA; Khalid SM; Ahmed A; Siddiqui BS; Saleem R; Siddiqui S; Faizi S Arzneimittelforschung; 1994 Aug; 44(8):972-5. PubMed ID: 7945545 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of various substituted oxadiazole derivatives. Kaur H; Kumar S; Verma RS; Garg A; Saxena KK; Lata S; Kumar A Arch Pharm (Weinheim); 2011 Jul; 344(7):466-73. PubMed ID: 21500249 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of benzyl-[3-(benzylamino-methyl)-cyclohexylmethyl]-amine derivatives. Kumar D; Joshi S; Rohilla RK; Roy N; Rawat DS Bioorg Med Chem Lett; 2010 Feb; 20(3):893-5. PubMed ID: 20047831 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial activity of 4-benzoyl-1-methyl-5-phenyl-1H-pyrazole-3-carboxylic acid and derivatives. Akbas E; Berber I; Sener A; Hasanov B Farmaco; 2005 Jan; 60(1):23-6. PubMed ID: 15652364 [TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. Bailey L; Gylfe A; Sundin C; Muschiol S; Elofsson M; Nordström P; Henriques-Normark B; Lugert R; Waldenström A; Wolf-Watz H; Bergström S FEBS Lett; 2007 Feb; 581(4):587-95. PubMed ID: 17257594 [TBL] [Abstract][Full Text] [Related]
13. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria. Keyser P; Elofsson M; Rosell S; Wolf-Watz H J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of N-[2-(5-bromothiophen-2-yl)-2-oxoethyl] and N-[(2-5-bromothiophen-2-yl)-2-oximinoethyl] derivatives of piperazinyl quinolones. Foroumadi A; Emami S; Mehni M; Moshafi MH; Shafiee A Bioorg Med Chem Lett; 2005 Oct; 15(20):4536-9. PubMed ID: 16115766 [TBL] [Abstract][Full Text] [Related]
15. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and in-vitro activity of new 1beta-methylcarbapenem derivatives as antibacterial agents. Jung MH; Hong JH; Cho JH; Oh CH Arch Pharm (Weinheim); 2008 Dec; 341(12):780-6. PubMed ID: 19009543 [TBL] [Abstract][Full Text] [Related]
17. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens. Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. Vicini P; Geronikaki A; Anastasia K; Incerti M; Zani F Bioorg Med Chem; 2006 Jun; 14(11):3859-64. PubMed ID: 16488614 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Emami S; Foroumadi A; Faramarzi MA; Samadi N Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives. Lee JS; Choa JH; Cho H; Oh CH Arch Pharm (Weinheim); 2004 Jul; 337(7):391-7. PubMed ID: 15237389 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]